Assessing Cost-Effectiveness and Key Value Drivers of Adjuvant Triglyceride Lowering Therapy in Management of Patients With a Rare Genetic Syndrome

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.891
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV